The BRI Blog

As part of an investigation by the U.S. Government Accountability Office, fake exchange accounts were granted federal insurance subsidies 90% of the time. This is taxpayer-funded fraud.

Expanding Medicare’s price controls into the private market would make the business of drug discovery all but impossible in the U.S.—and mark the end of America’s reign as the world’s leading source of life-saving medicines.

A chaotic FDA is incompatible with a thriving, competitive market for medical discovery. Any effort to reform the agency must prioritize removing barriers and avoiding delays that keep safe, effective medicines from reaching patients.

A mix of catastrophic coverage, HSAs, and direct primary care can help Americans get better care at a lower cost than a conventional Obamacare plan. Here’s how.